$EVEX
Eve Holding, Inc.

2023 Q1 Form 10-K Financial Statement

#000155485523000184 Filed on March 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.154M $8.964M $32.86M
YoY Change 660.95% 575.25% 438.53%
% of Gross Profit
Research & Development $21.53M $18.03M $51.86M
YoY Change 136.19% 35.75% 290.5%
% of Gross Profit
Depreciation & Amortization $22.05K $24.88K $24.88K
YoY Change -76.95% -76.95%
% of Gross Profit
Operating Expenses $27.68M $26.99M $84.71M
YoY Change 178.96% 1933.19% 1288.5%
Operating Profit -$27.68M -$189.5M
YoY Change 165.34% 942.37%
Interest Expense $2.084M $7.249M $16.39M
YoY Change 368.48% -449.78% -20.51%
% of Operating Profit
Other Income/Expense, Net $34.00K $122.0K
YoY Change -253.02% -258.44%
Pretax Income -$25.60M -$19.74M -$173.1M
YoY Change 169.43% 480.61% -1291.98%
Income Tax $173.7K $312.9K $933.0K
% Of Pretax Income
Net Earnings -$25.77M -$20.05M -$174.0M
YoY Change 171.26% 489.81% -1298.41%
Net Earnings / Revenue
Basic Earnings Per Share -$0.09 -$0.68
Diluted Earnings Per Share -$0.09 -$0.07 -$0.68
COMMON SHARES
Basic Shares Outstanding 269.1M shares 266.4M shares 254.1M shares
Diluted Shares Outstanding 275.5M shares 254.1M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $211.0M $227.9M $227.9M
YoY Change 854668.4% 47850.44% 47850.44%
Cash & Equivalents $11.84M $49.15M $49.15M
Short-Term Investments $199.1M $178.8M $178.8M
Other Short-Term Assets $740.7K $1.426M $1.426M
YoY Change 772.44% 6643.17% 1429.52%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $295.5M $312.2M $312.2M
YoY Change 269599.44% 2035.82% 54814.82%
LONG-TERM ASSETS
Property, Plant & Equipment $594.3K $451.6K $668.2K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $801.5K $668.2K $668.2K
YoY Change -99.66% -4.51% -99.72%
TOTAL ASSETS
Total Short-Term Assets $295.5M $312.2M $312.2M
Total Long-Term Assets $801.5K $668.2K $668.2K
Total Assets $296.3M $312.9M $312.9M
YoY Change 25.01% 1942.61% 31.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $490.1K $2.097M $2.097M
YoY Change -91.41% 138.95% -55.77%
Accrued Expenses $5.046M $2.492M
YoY Change 418.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.86M $24.93M $24.93M
YoY Change 460.89% 1533.86% 425.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $976.3K $1.020M $1.020M
YoY Change -96.04% 45.12% -96.77%
Total Long-Term Liabilities $976.3K $1.020M $1.020M
YoY Change -96.04% 45.12% -96.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.86M $24.93M $24.93M
Total Long-Term Liabilities $976.3K $1.020M $1.020M
Total Liabilities $33.84M $25.95M $25.95M
YoY Change 10.84% 1064.37% -28.63%
SHAREHOLDERS EQUITY
Retained Earnings -$242.8M -$217.0M
YoY Change
Common Stock $505.3M $503.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $262.5M $286.9M $286.9M
YoY Change
Total Liabilities & Shareholders Equity $296.3M $312.9M $312.9M
YoY Change 25.01% 1942.61% 31.74%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$25.77M -$20.05M -$174.0M
YoY Change 171.26% 489.81% -1298.41%
Depreciation, Depletion And Amortization $22.05K $24.88K $24.88K
YoY Change -76.95% -76.95%
Cash From Operating Activities -$19.89M -$20.74M -$59.46M
YoY Change 3211.54% 3361.63% 3873.19%
INVESTING ACTIVITIES
Capital Expenditures $43.70K $57.75K $476.5K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$17.50M -$8.000M -$258.0M
YoY Change 247.83% 5508.7%
Cash From Investing Activities -$17.54M -$8.058M -$258.5M
YoY Change 250.34% 5519.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 $352.7M
YoY Change -100.0% -100.0% 7567.47%
NET CHANGE
Cash From Operating Activities -$19.89M -20.74M -$59.46M
Cash From Investing Activities -$17.54M -8.058M -$258.5M
Cash From Financing Activities $0.00 0.000 $352.7M
Net Change In Cash -$37.31M -28.80M $34.77M
YoY Change 8178.72% 4706.67% -2423.44%
FREE CASH FLOW
Cash From Operating Activities -$19.89M -$20.74M -$59.46M
Capital Expenditures $43.70K $57.75K $476.5K
Free Cash Flow -$19.93M -$20.80M -$59.93M
YoY Change 3218.82% 3905.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
269094021 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2022 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Assets
Assets
21570673 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2097097 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
877641 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
12625243 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
8642340 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3562500 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
32226 usd
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001823652
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2020 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39704
CY2022 dei Entity Registrant Name
EntityRegistrantName
EVE HOLDING, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2549808
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1400 General Aviation Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Melbourne
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32935
CY2022 dei City Area Code
CityAreaCode
(321)
CY2022 dei Local Phone Number
LocalPhoneNumber
751-5050
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
1638000000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
269094021 shares
CY2022 dei Auditor Firm
AuditorFirmId
185
CY2022 dei Auditor Name
AuditorName
KPMG LLP
CY2022 dei Auditor Location
AuditorLocation
Miami, Florida
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49146063 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14376523 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
178781549 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
203712 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
220000 usd
CY2022Q4 evex Loans Receivable Related Parties Current
LoansReceivableRelatedPartiesCurrent
82650375 usd
CY2021Q4 evex Loans Receivable Related Parties Current
LoansReceivableRelatedPartiesCurrent
0 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1425507 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6274397 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
312207206 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
20870920 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
451586 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
216636 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
699753 usd
CY2022Q4 us-gaap Assets
Assets
312875428 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6648171 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
616156 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24933011 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10168363 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1020074 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702921 usd
CY2022Q4 us-gaap Liabilities
Liabilities
25953085 usd
CY2021Q4 us-gaap Liabilities
Liabilities
10871284 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
269094021 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
269094021 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
220000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
220000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
269094 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
220000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
503661571 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53489579 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-217008322 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42977964 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32226 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
286922343 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10699389 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
312875428 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21570673 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51857545 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13279780 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8358043 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32855959 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4898942 usd
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1233876 usd
CY2022 evex Expense Related To Issuance Of New Warrants
ExpenseRelatedToIssuanceOfNewWarrants
104776230 usd
CY2021 evex Expense Related To Issuance Of New Warrants
ExpenseRelatedToIssuanceOfNewWarrants
0 usd
CY2020 evex Expense Related To Issuance Of New Warrants
ExpenseRelatedToIssuanceOfNewWarrants
0 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-189489734 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-18178722 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-9591919 usd
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
9547500 usd
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-77147 usd
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-34023 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-173097378 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18255869 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9625942 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
932980 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-174030358 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18255869 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9625942 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
254131038 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
254131038 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220000000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220000000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220000000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220000000 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-174030358 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18255869 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9625942 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-77664 usd
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
46012 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-174030358 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18333533 usd
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9579930 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-479205 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9625942 usd
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
46012 usd
CY2020 evex Increase Decrease Through Net Transfer From Parent Equity
IncreaseDecreaseThroughNetTransferFromParentEquity
9045282 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1013853 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18255869 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-77664 usd
CY2021 evex Increase Decrease Through Net Transfer From Parent Equity
IncreaseDecreaseThroughNetTransferFromParentEquity
30046775 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10699389 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-174030358 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15000000 usd
CY2022 evex Increase Decrease Through Reclassification Of Public Warrants From Liability
IncreaseDecreaseThroughReclassificationOfPublicWarrantsFromLiability
10580000 usd
CY2022 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
104776230 usd
CY2022 evex Stock Issued During Period Value Reverse Recapitalization Net Of Fees
StockIssuedDuringPeriodValueReverseRecapitalizationNetOfFees
315326717 usd
CY2022 evex Stock Issued During Period Value Restricted Stock Units And Restricted Stock Units Expense
StockIssuedDuringPeriodValueRestrictedStockUnitsAndRestrictedStockUnitsExpense
3301392 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35226 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3282000 usd
CY2022 evex Increase Decrease Through Net Transfer From Parent Equity
IncreaseDecreaseThroughNetTransferFromParentEquity
732776 usd
CY2022 evex Decrease Increase Through Net Distributions To Parent Equity
DecreaseIncreaseThroughNetDistributionsToParentEquity
2105409 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
286922343 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-174030358 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18255869 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9625942 usd
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 usd
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
107931 usd
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
9056 usd
CY2022 us-gaap Depreciation
Depreciation
24879 usd
CY2021 us-gaap Depreciation
Depreciation
0 usd
CY2020 us-gaap Depreciation
Depreciation
0 usd
CY2022 evex Noncash Lease Expenses Amortization And Interest
NoncashLeaseExpensesAmortizationAndInterest
8914 usd
CY2021 evex Noncash Lease Expenses Amortization And Interest
NoncashLeaseExpensesAmortizationAndInterest
0 usd
CY2020 evex Noncash Lease Expenses Amortization And Interest
NoncashLeaseExpensesAmortizationAndInterest
0 usd
CY2022 evex Long Term Incentive Plan Expense Income
LongTermIncentivePlanExpenseIncome
947 usd
CY2021 evex Long Term Incentive Plan Expense Income
LongTermIncentivePlanExpenseIncome
150099 usd
CY2020 evex Long Term Incentive Plan Expense Income
LongTermIncentivePlanExpenseIncome
-736 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3301392 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
98537955 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3431924 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4840322 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6270287 usd
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1379 usd
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-206806 usd
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
220000 usd
CY2020 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
0 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1924083 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
30653 usd
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
527376 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
2872871 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
8642340 usd
CY2020 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8914 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
6295481 usd
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
929123 usd
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
62836 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59457546 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14886010 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9028789 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
177000000 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2022 evex Payments To Fund Short Term Loans To Related Parties
PaymentsToFundShortTermLoansToRelatedParties
81000000 usd
CY2021 evex Payments To Fund Short Term Loans To Related Parties
PaymentsToFundShortTermLoansToRelatedParties
0 usd
CY2020 evex Payments To Fund Short Term Loans To Related Parties
PaymentsToFundShortTermLoansToRelatedParties
0 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
476465 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-258476465 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
CY2021 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
14262533 usd
CY2020 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
9028789 usd
CY2022 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
369830250 usd
CY2021 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
15000000 usd
CY2020 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0 usd
CY2022 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
15754066 usd
CY2021 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 usd
CY2020 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 usd
CY2022 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
1372633 usd
CY2021 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
0 usd
CY2020 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
352703551 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29262533 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9028789 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34769540 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14376523 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14376523 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49146063 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14376523 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022 us-gaap Contribution Of Property
ContributionOfProperty
0 usd
CY2021 us-gaap Contribution Of Property
ContributionOfProperty
784241 usd
CY2020 us-gaap Contribution Of Property
ContributionOfProperty
16494 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
970253 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 evex Increase Decrease In Operating Assets Right Of Use
IncreaseDecreaseInOperatingAssetsRightOfUse
224210 usd
CY2021 evex Increase Decrease In Operating Assets Right Of Use
IncreaseDecreaseInOperatingAssetsRightOfUse
0 usd
CY2020 evex Increase Decrease In Operating Assets Right Of Use
IncreaseDecreaseInOperatingAssetsRightOfUse
0 usd
CY2022 evex Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-224210 usd
CY2021 evex Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0 usd
CY2020 evex Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14376523 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
220000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6274397 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
20870920 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
699753 usd
CY2021Q4 us-gaap Assets
Assets
21570673 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
877641 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
8642340 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
32226 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
616156 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10168363 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702921 usd
CY2021Q4 us-gaap Liabilities
Liabilities
10871284 usd
CY2021Q4 evex Net Parent Investment
NetParentInvestment
10731615 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32226 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10699389 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21570673 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates </span></p><p style="margin: 8pt 0pt 0pt; text-indent: 22.5pt; line-height: 1.2; font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="line-height: inherit;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognize that the actual results could be materially different from the estimates. Until December 31, 2021, under the management approach, the s</span><span style="line-height: inherit; margin: 8pt 0pt; text-align: justify; text-indent: 20pt;"><span style="line-height: inherit;">ignificant estimates inherent in the preparation of the audited consolidated financial statements include, but are not limited to, useful lives of capitalized software, net, accrued liabilities, income taxes including deferred tax assets and liabilities. Under the legal entity approach, the significant estimates include, </span></span><span style="line-height: inherit;">but are not limited to the warrants measurement, fair value measurement and income taxes.</span></span></p>
CY2022 us-gaap Derivatives Methods Of Accounting Hedge Documentation
DerivativesMethodsOfAccountingHedgeDocumentation
<p style="font-size: 10pt; line-height: 1.2; margin: 0px; text-align: justify; text-indent: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold; line-height: inherit;">Hedge accounting</span></p><p style="line-height: 1.2; text-align: justify; text-indent: 0px; margin: 0px;"><br/></p><p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Until December 31, 2021, the Company accounted for certain derivative instruments under the cash flow hedge accounting methodology to hedge against the payroll cash flow volatility attributable to a risk of foreign exchange rate fluctuation associated with highly probable forecast transactions that will affect income or loss for the year. Effective January 1, 2022, no hedge transactions were observed since the derivative contracts were not transferred to Eve. </span></p><p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. For derivatives designated in hedging relationships changes in the fair value are recognized in Accumulated Other Comprehensive Loss (“AOCI”), to the extent the derivative is effective at offsetting the changes in cash flows being hedged until the hedged item affects earnings. The cash flow impact of the derivative instruments is included in our combined statement of cash flows in net cash used in operating activities. </span></p><p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The Company only enters into derivative contracts that it intends to designate as a hedge of a forecasted transaction or the variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). For all hedging relationships, Eve formally documents the hedging relationship and its risk-management objective and strategy for undertaking the hedge, the hedging instrument, the hedged transaction, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness. The Company also formally assesses, both at the inception of the hedging relationship and on an ongoing basis, whether the derivatives that are used in hedging relationships are highly effective in offsetting changes in cash flows of hedged transactions. For derivative instruments that are designated and qualify as part of a cash flow hedging relationship, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive loss and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.</span></p><div><div id="t_ft_46FRHKFJY800000000000000000000b"/></div><p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Eve discontinues hedge accounting prospectively when it determines that the derivative is no longer effective in offsetting cash flows attributable to the hedged risk, the derivative expires or is sold, terminated, or exercised, the cash flow hedge is designated because a forecasted transaction is not probable of occurring, or management determines to remove the designation of the cash flow hedge. Additionally, when it is probable that a forecasted transaction will not occur, Eve recognizes immediately in earnings gains and losses that were accumulated in other comprehensive loss related to the hedging relationship.</span></p><p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><span style="line-height: inherit;">In all situations in which hedge accounting is discontinued and the derivative remains outstanding, Eve</span><span style="line-height: inherit;"> continues to carry the derivative at its fair value on the balance sheet and recognizes any subsequent changes in its fair value in earnings.</span></span></p>
CY2022 evex Number Of Tranches Granted Under Share Based Payment Award
NumberOfTranchesGrantedUnderShareBasedPaymentAward
10 number
CY2022 evex Number Of Tranches Granted Under Share Based Payment Award For Service Conditions
NumberOfTranchesGrantedUnderShareBasedPaymentAwardForServiceConditions
4 number
CY2022Q4 evex Number Of Tranches Granted Under Share Based Payment Award For Market And Service Conditions
NumberOfTranchesGrantedUnderShareBasedPaymentAwardForMarketAndServiceConditions
2 number
CY2022 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50%
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 pure
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
CY2022 us-gaap Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
<p style="margin: 0px; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-indent: 0px;"><span style="font-family: 'times new roman', times; line-height: inherit; font-size: 10pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: black; line-height: inherit;">Derivative Financial Instruments</span></b></span></p><p style="margin: 0pt; text-align: justify; font-size: 7pt; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> </span></p><p style="margin: 0cm 0cm 0.0001pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit; margin: 8pt 0cm; text-align: justify; text-indent: 20pt; font-family: 'times new roman', times;"><span style="color: #000000; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">       The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>”. The Company’s derivative instruments, including liability classified warrants, are recorded at fair value and re-valued at each reporting date, with changes in the fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.  </span></span></p>
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
82854087 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
12625243 usd
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
220000 usd
CY2022Q4 us-gaap Cash
Cash
14446534 usd
CY2021Q4 us-gaap Cash
Cash
14131396 usd
CY2022Q4 evex Private Securities At Carrying Value
PrivateSecuritiesAtCarryingValue
4483260 usd
CY2021Q4 evex Private Securities At Carrying Value
PrivateSecuritiesAtCarryingValue
245127 usd
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
30216269 usd
CY2021Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49146063 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14376523 usd
CY2022 evex Allocated Corporate Costs Income Net From Transactions With Related Party
AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty
-2101356 usd
CY2021 evex Allocated Corporate Costs Income Net From Transactions With Related Party
AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty
-16701385 usd
CY2022 evex Allocated Corporate Costs Income Net From Transactions With Related Party
AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty
-2101356 usd
CY2021 evex Allocated Corporate Costs Income Net From Transactions With Related Party
AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty
-16701385 usd
CY2021 evex Transaction Costs Recognized As Expense Related To Carve Out
TransactionCostsRecognizedAsExpenseRelatedToCarveOut
1800000 usd
CY2021 evex Transaction Costs Recognized As Expense Directly Related
TransactionCostsRecognizedAsExpenseDirectlyRelated
6300000 usd
CY2021 evex Transaction Costs Recognized As Expense Related To Other
TransactionCostsRecognizedAsExpenseRelatedToOther
500000 usd
CY2021 evex Transaction Costs Incurred
TransactionCostsIncurred
8600000 usd
evex Transaction Costs Recognized As Expense Related To Carve Out
TransactionCostsRecognizedAsExpenseRelatedToCarveOut
600000 usd
evex Transaction Costs Recognized As Expense Directly Related
TransactionCostsRecognizedAsExpenseDirectlyRelated
15100000 usd
evex Transaction Costs Recognized As Expense Related To Other
TransactionCostsRecognizedAsExpenseRelatedToOther
0 usd
evex Transaction Costs Incurred
TransactionCostsIncurred
15700000 usd
CY2022 evex Transaction Costs Recognized As Expense Related To Carve Out
TransactionCostsRecognizedAsExpenseRelatedToCarveOut
2400000 usd
CY2022 evex Transaction Costs Recognized As Expense Directly Related
TransactionCostsRecognizedAsExpenseDirectlyRelated
21400000 usd
CY2022 evex Transaction Costs Recognized As Expense Related To Other
TransactionCostsRecognizedAsExpenseRelatedToOther
500000 usd
CY2022 evex Transaction Costs Incurred
TransactionCostsIncurred
24300000 usd
CY2021 evex Transaction Costs Recognized As Expense Directly Related
TransactionCostsRecognizedAsExpenseDirectlyRelated
6300000 usd
CY2021 evex Transaction Cost Incurred Which Related To Impact To Statement Of Operations
TransactionCostIncurredWhichRelatedToImpactToStatementOfOperations
2400000 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
12625243 usd
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
39485512 usd
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
82854087 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
12625243 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8642340 usd
CY2022 evex Operating Income Loss Net From Transactions With Related Party
OperatingIncomeLossNetFromTransactionsWithRelatedParty
46162036 usd
CY2021 evex Operating Income Loss Net From Transactions With Related Party
OperatingIncomeLossNetFromTransactionsWithRelatedParty
3498428 usd
CY2020 evex Operating Income Loss Net From Transactions With Related Party
OperatingIncomeLossNetFromTransactionsWithRelatedParty
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
451586 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33495 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
0 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
34642 usd
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0 usd
CY2022Q4 evex Advances To Employees
AdvancesToEmployees
74064 usd
CY2021Q4 evex Advances To Employees
AdvancesToEmployees
17063 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
24484 usd
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4077 usd
CY2022Q4 evex Deferred Transaction Costs Net Current
DeferredTransactionCostsNetCurrent
0 usd
CY2021Q4 evex Deferred Transaction Costs Net Current
DeferredTransactionCostsNetCurrent
6253257 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1425507 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6274397 usd
CY2019Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16005 usd
CY2020 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
7438 usd
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
23443 usd
CY2021 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
676310 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
699753 usd
CY2022 us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-699753 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0 usd
CY2022Q4 evex Provision For Profit Sharing Program
ProvisionForProfitSharingProgram
2508143 usd
CY2021Q4 evex Provision For Profit Sharing Program
ProvisionForProfitSharingProgram
59855 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2491847 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q4 evex Advances From Customers Current
AdvancesFromCustomersCurrent
800000 usd
CY2021Q4 evex Advances From Customers Current
AdvancesFromCustomersCurrent
405000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
763031 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
455392 usd
CY2022Q4 evex Social Charges Payable Current
SocialChargesPayableCurrent
626627 usd
CY2021Q4 evex Social Charges Payable Current
SocialChargesPayableCurrent
163384 usd
CY2022Q4 evex Advanced Payments Related To Service Arrangements
AdvancedPaymentsRelatedToServiceArrangements
300738 usd
CY2021Q4 evex Advanced Payments Related To Service Arrangements
AdvancedPaymentsRelatedToServiceArrangements
52405 usd
CY2022Q4 evex Long Term Incentive Plan
LongTermIncentivePlan
177859 usd
CY2021Q4 evex Long Term Incentive Plan
LongTermIncentivePlan
183041 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
7668245 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1319077 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6648171 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
616156 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1020074 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702921 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
269094021 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
269094021 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
220000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
220000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote per share
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11822536 shares
CY2021Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
32226 usd
CY2022 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0 usd
CY2021 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0 usd
CY2020 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
46012 usd
CY2020 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
687235 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.08
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M2D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
489937 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.62
CY2022Q2 evex Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1
P3Y2M15D
CY2022Q4 evex Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod
-140000 shares
evex Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
11.32
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
120000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.32
evex Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
P0Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
917172 shares
CY2022Q4 evex Share Based Compensation Arrangement By Share Based Payment Award Options Convertible In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConvertibleInPeriod
0 shares
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3301392 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51857545 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13279780 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8358043 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-189489734 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-18178722 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-9591919 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-174747260 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6481431 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1742747 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1649882 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-11774438 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-7883195 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-173097378 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18255869 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9625942 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
932980 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
932980 usd
CY2022 evex Income Tax Expense Benefit Current
IncomeTaxExpenseBenefitCurrent
0 usd
CY2022 evex Current Income Tax Expense Benefit Valuation Allowance
CurrentIncomeTaxExpenseBenefitValuationAllowance
932980 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-25625749 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
53875077 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-277414 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
27971914 usd
CY2022 evex Deferred Income Tax Expense Benefit Valuation Allowance
DeferredIncomeTaxExpenseBenefitValuationAllowance
-27971914 usd
CY2022 evex Income Tax Expense Benefit Deferred
IncomeTaxExpenseBenefitDeferred
0 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2021 evex Income Tax Expense Benefit Current
IncomeTaxExpenseBenefitCurrent
0 usd
CY2021 evex Current Income Tax Expense Benefit Valuation Allowance
CurrentIncomeTaxExpenseBenefitValuationAllowance
0 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-309318015 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-85682832 usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-3929123 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-398929970 usd
CY2021 evex Deferred Income Tax Expense Benefit Valuation Allowance
DeferredIncomeTaxExpenseBenefitValuationAllowance
398929970 usd
CY2021 evex Income Tax Expense Benefit Deferred
IncomeTaxExpenseBenefitDeferred
0 usd
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2020 evex Income Tax Expense Benefit Current
IncomeTaxExpenseBenefitCurrent
0 usd
CY2020 evex Current Income Tax Expense Benefit Valuation Allowance
CurrentIncomeTaxExpenseBenefitValuationAllowance
0 usd
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-374301 usd
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-87114 usd
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2680556 usd
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3141971 usd
CY2020 evex Deferred Income Tax Expense Benefit Valuation Allowance
DeferredIncomeTaxExpenseBenefitValuationAllowance
3141971 usd
CY2020 evex Income Tax Expense Benefit Deferred
IncomeTaxExpenseBenefitDeferred
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.3112 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.055 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05 pure
CY2022 evex Effective Income Tax Rate Reconciliation Reserves Income Taxes
EffectiveIncomeTaxRateReconciliationReservesIncomeTaxes
0 pure
CY2021 evex Effective Income Tax Rate Reconciliation Reserves Income Taxes
EffectiveIncomeTaxRateReconciliationReservesIncomeTaxes
0 pure
CY2020 evex Effective Income Tax Rate Reconciliation Reserves Income Taxes
EffectiveIncomeTaxRateReconciliationReservesIncomeTaxes
0 pure
CY2022 evex Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.1371 pure
CY2021 evex Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.0275 pure
CY2020 evex Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0014 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0823 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.11 pure
CY2022 evex Effective Income Tax Rate Reconciliation Intangibles Percent
EffectiveIncomeTaxRateReconciliationIntangiblesPercent
0.0074 pure
CY2021 evex Effective Income Tax Rate Reconciliation Intangibles Percent
EffectiveIncomeTaxRateReconciliationIntangiblesPercent
-21.4516 pure
CY2020 evex Effective Income Tax Rate Reconciliation Intangibles Percent
EffectiveIncomeTaxRateReconciliationIntangiblesPercent
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.0654 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0 pure
CY2022 evex Effective Income Tax Rate Reconciliation Valuation Allowance Income Taxes
EffectiveIncomeTaxRateReconciliationValuationAllowanceIncomeTaxes
0.1616 pure
CY2021 evex Effective Income Tax Rate Reconciliation Valuation Allowance Income Taxes
EffectiveIncomeTaxRateReconciliationValuationAllowanceIncomeTaxes
21.1318 pure
CY2020 evex Effective Income Tax Rate Reconciliation Valuation Allowance Income Taxes
EffectiveIncomeTaxRateReconciliationValuationAllowanceIncomeTaxes
-0.37 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0053 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
329958033 usd
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
391617310 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
37549858 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14614700 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
12523243 usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0 usd
CY2022Q4 evex Deferred Tax Assets Federal Research And Development Credit
DeferredTaxAssetsFederalResearchAndDevelopmentCredit
351985 usd
CY2021Q4 evex Deferred Tax Assets Federal Research And Development Credit
DeferredTaxAssetsFederalResearchAndDevelopmentCredit
351985 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1916438 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
64178 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-301857 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 usd
CY2022Q4 evex Deferred Tax Assets Uncertain Tax Position Research And Development Reserve
DeferredTaxAssetsUncertainTaxPositionResearchAndDevelopmentReserve
-70397 usd
CY2021Q4 evex Deferred Tax Assets Uncertain Tax Position Research And Development Reserve
DeferredTaxAssetsUncertainTaxPositionResearchAndDevelopmentReserve
-70397 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
381927303 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
406577776 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
381927303 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
406577776 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
24650473 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-174030358 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18255869 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9625942 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
254131038 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
254131038 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220000000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220000000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220000000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220000000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57840248 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57840248 shares
CY2021Q3 us-gaap Number Of Properties Subject To Ground Leases
NumberOfPropertiesSubjectToGroundLeases
2 number

Files In Submission

Name View Source Status
0001554855-23-000184-index-headers.html Edgar Link pending
0001554855-23-000184-index.html Edgar Link pending
0001554855-23-000184.txt Edgar Link pending
0001554855-23-000184-xbrl.zip Edgar Link pending
evex-20221231.htm Edgar Link pending
evex-20221231.xsd Edgar Link pending
ex231_2.htm Edgar Link pending
ex232_3.htm Edgar Link pending
ex43_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
imgbaaf0dbd1d214ac79cd1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
evex-20221231_def.xml Edgar Link unprocessable
evex-20221231_lab.xml Edgar Link unprocessable
evex-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
evex-20221231_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
evex-20221231_cal.xml Edgar Link unprocessable